This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Palinski, W. Search for Related Content PubMed PubMed Citation Articles by Palinski, W. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CHOLESTEROL Related Collections Related Article

(Circulation Research. 2009;104:569.)
© 2009 American Heart Association, Inc.

Editorials

Maternal–Fetal Cholesterol Transport in the Placenta

Good, Bad, and Target for Modulation

Wulf Palinski

From the Department of Medicine, University of California San Diego.

Correspondence to Wulf Palinski, MD, FRCP, University of California, San Diego, Department of Medicine 0682, 9500 Gilman Dr, La Jolla, CA 92093-0682. E-mail wpalinski@ucsd.edu

See related articles, pages 600–608

Key Words: placenta • endothelial cells • cholesterol transport • developmental programming • arteriosclerosis

An extract of the first 250 words of the full text is provided, because this article has no abstract.

The transport of cholesterol from mother to fetus across the placental barrier has long been neglected. Although cholesterol is of vital importance for fetal development as a key constituent of cell membranes, precursor of steroid hormones and metabolic regulators (oxysterols), and a modulator of hedgehog signaling, it was generally assumed that most of it is synthesized de novo by the fetus and, to a lesser extent, by cells on the fetal side of the placenta. A contribution of placental cholesterol to fetal growth was supported by the fact that LDL-cholesterol concentrations in the umbilical cord vein (which delivers placental blood to the fetus) are greater than those in umbilical arteries,¹ and by the ability of placental cells to secrete apolipoprotein (apo)B-containing particles.² On the other hand, the case against maternal cholesterol transfer was based on the observation that the placental barrier is impermeable to labeled LDL and other lipoprotein particles and that genetically normal offspring of hypercholesterolemic mothers generally have very low cholesterol levels at term birth, whereas maternal cholesterol tends to be highest in the third trimester.

Given the essential role of independent cholesterol synthesis, it is not surprising that most of the known genetic defects of cholesterol biosynthesis in fetuses severely impact their development and survival. The one exception is the Smith–Lemli–Opitz syndrome (SLO), a defect in the conversion of 7-dihydrocholesterol to cholesterol.³ Children with SLO are born relatively healthy and must therefore have obtained a minimum of cholesterol from the mother. Interest in potential mechanisms transporting cholesterol . . . [Full Text of this Article]

Related Article:

Human Endothelial Cells of the Placental Barrier Efficiently Deliver Cholesterol to the Fetal Circulation via ABCA1 and ABCG1

Jasminka Stefulj, Ute Panzenboeck, Tatjana Becker, Birgit Hirschmugl, Cornelia Schweinzer, Ingrid Lang, Gunther Marsche, Anton Sadjak, Uwe Lang, Gernot Desoye, and Christian Wadsack
Circ. Res. 2009 104: 600-608. [Abstract] [Full Text] [PDF]